What is the current stock price of Nascent Biotech, Inc. (NBIO)?

As of the latest market data, Nascent Biotech, Inc. (NBIO) is trading at $0.00. The stock has seen a loss of 0.00% today.

Does Nascent Biotech, Inc. (NBIO) pay a dividend?

Based on current data, Nascent Biotech, Inc. does not have a confirmed active dividend policy.

What is the market cap of Nascent Biotech, Inc.?

The current market capitalization of Nascent Biotech, Inc. (NBIO) is approximately unavailable.

NBIO

Nascent Biotech, Inc.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.13

Company Profile

Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. In addition, the company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. Nascent Biotech, Inc. is based in Vero Beach, Florida.

Sector

Healthcare

Industry

Biotechnology

IPO Date

2009-12-03

Beta

2.45

Websitewww.nascentbiotech.com↗